Annual Drug Patent Expirations for NUBEQA
Nubeqa is a drug marketed by Bayer Healthcare and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
This drug has ninety-six patent family members in thirty-six countries.
The generic ingredient in NUBEQA is darolutamide. One supplier is listed for this compound. Additional details are available on the darolutamide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published at New patent for Bayer Healthcare drug NUBEQA
You must log in to post a comment.